MedTrace Logo

Integration of VR and AR Dementia Prevention Health Education Progrom for Older Adults With Mild Cognitive Impairment

NCT06888986 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2026-02-19

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to evaluate the effectiveness of Virtual Reality (VR)-based cognitive health education for older adults with mild cognitive impairment (MCI) in Taiwan. The study aims to assess whether VR-supported interventions improve cognitive health knowledge, health literacy, and self-management skills among participants.

The primary research questions are:

1. Does the VR-based intervention enhance participants' knowledge related to dementia and their health literacy?
2. Does the VR-based intervention improve cognitive function, mental well-being, and self-efficacy compared to a control group?

Participants will be randomly assigned to one of two groups:

1. Intervention group: This group will receive the "VR Dementia Prevention Health Education Module," an immersive virtual reality program designed to enhance dementia-related knowledge and coping strategies.
2. Control group: This group will receive standard, routine health education without VR exposure.

Conditions

  • Mild Cognitive Impairment (MCI)
  • Dementia
  • Health Literacy
  • Self-Efficacy
  • Attitude to Health
  • Virtual Reality
  • Health Education
  • eHealth
  • Older Adults (65 Years and Older)

Interventions

BEHAVIORAL

VR Dementia Prevention Health Education Module

A virtual reality (VR) cognitive health education program designed to enhance knowledge related to dementia, improve health literacy, boost self-efficacy, and shape attitudes towards dementia. Participants engage with 360-degree immersive VR modules using VR headsets that simulate real-world scenarios related to dementia. The intervention comprises five interactive VR sessions, each addressing important topics in dementia prevention and management. Trained research staff will guide participants to ensure safe and effective interaction with the VR system.

Sponsors & Collaborators

  • National Taiwan Normal University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2025-05-08
Completion
2025-08-10

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06888986 on ClinicalTrials.gov